Japan’s Pharmas Need R&D Reform: Tokyo Conference
This article was originally published in PharmAsia News
Executive Summary
TOKYO - The pharmaceutical market is rapidly increasing in complexity and pharmaceutical companies need to strengthen their 'mekiki ryoku' - translated 'eye for good judgment' in Japanese - said Ryoichi Inoue of Pharma Marketing Consultant, who is a former marketing executive at Roche in Japan